(VIANEWS) – Yandex (YNDX), Axcelis Technologies (ACLS), Santander Consumer USA Holdings (SC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Yandex (YNDX)

48.3% sales growth and 4.4% return on equity

Yandex N.V., an Internet and technology company, provides Internet search engine in Russia and internationally.

Yandex’s sales growth this year is anticipated to be 60.7% and 35.7% for next year.

Year-on-year quarterly revenue growth grew by 96.6%, now sitting on 284.47B for the twelve trailing months.

Volume

Today’s last reported volume for Yandex is 981959 which is 12.97% below its average volume of 1128380.

Yandex’s sales growth for the next quarter is 48.3%. The company’s growth estimates for the present quarter and the next is a negative 82.8% and negative -4.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.4%.

Volatility

Yandex’s last day, last week, and last month’s current volatility was 1.18%, 1.48%, and 1.51%, respectively.

Yandex’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.07% (day), 2.29% (last week), and 2.10% (last month), respectively.

Yandex’s Stock Yearly Top and Bottom Value

Yandex’s stock is valued at $77.16 at 06:22 EST, below its 52-week high of $82.62 and way higher than its 52-week low of $55.62.

Yandex’s Moving Average

Yandex’s value is under its 50-day moving average of $78.21 and way above its 200-day moving average of $69.72.

2. Axcelis Technologies (ACLS)

43.6% sales growth and 12.96% return on equity

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide.

Axcelis Technologies’s sales growth this year is anticipated to be 31.8% and 10.4% for next year.

Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 512.65M for the twelve trailing months.

Volume

Today’s last reported volume for Axcelis Technologies is 161058 which is 26.53% below its average volume of 219229.

Axcelis Technologies’s sales growth for the next quarter is 43.6%. The company’s growth estimates for the current quarter and the next is 131.2% and 134.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.96%.

Volatility

Axcelis Technologies’s last day, last week, and last month’s current volatility was 0.59%, 2.30%, and 1.79%, respectively.

Axcelis Technologies’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.26% (day), 3.33% (last week), and 3.04% (last month), respectively.

Axcelis Technologies’s Stock Yearly Top and Bottom Value

Axcelis Technologies’s stock is valued at $47.18 at 06:22 EST, way under its 52-week high of $52.80 and way above its 52-week low of $21.69.

Axcelis Technologies’s Moving Average

Axcelis Technologies’s worth is under its 50-day moving average of $48.38 and way higher than its 200-day moving average of $42.47.

3. Santander Consumer USA Holdings (SC)

27.1% sales growth and 46.37% return on equity

Santander Consumer USA Holdings Inc., a specialized consumer finance company, provides vehicle finance and third-party servicing in the United States.

Santander Consumer USA Holdings’s sales growth this year is expected to be 32% and 5.9% for next year.

Year-on-year quarterly revenue growth grew by 165.8%, now sitting on 6.52B for the twelve trailing months.

Volume

Today’s last reported volume for Santander Consumer USA Holdings is 462337 which is 62.19% below its average volume of 1222800.

Santander Consumer USA Holdings’s sales growth for the next quarter is 27.1%. The company’s growth estimates for the present quarter and the next is 31.6% and negative -4.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.37%.

Volatility

Santander Consumer USA Holdings’s last day, last week, and last month’s current volatility was 0.05%, 0.06%, and 0.15%, respectively.

Santander Consumer USA Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.36% (day), 0.29% (last week), and 0.35% (last month), respectively.

Santander Consumer USA Holdings’s Stock Yearly Top and Bottom Value

Santander Consumer USA Holdings’s stock is valued at $41.68 at 06:22 EST, under its 52-week high of $42.39 and way higher than its 52-week low of $19.77.

Santander Consumer USA Holdings’s Moving Average

Santander Consumer USA Holdings’s worth is higher than its 50-day moving average of $41.51 and higher than its 200-day moving average of $37.97.

4. Corcept Therapeutics Incorporated (CORT)

21.3% sales growth and 19.99% return on equity

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States.

Corcept Therapeutics Incorporated’s sales growth this year is anticipated to be 5.3% and 14.7% for next year.

Year-on-year quarterly revenue growth grew by 3.4%, now sitting on 343.09M for the twelve trailing months.

Volume

Today’s last reported volume for Corcept Therapeutics Incorporated is 348425 which is 27.83% below its average volume of 482798.

Corcept Therapeutics Incorporated’s sales growth is a negative 0% for the current quarter and 21.3% for the next. The company’s growth estimates for the current quarter and the next is 17.6% and 10%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.99%.

Volatility

Corcept Therapeutics Incorporated’s last day, last week, and last month’s current volatility was 2.52%, 1.57%, and 1.14%, respectively.

Corcept Therapeutics Incorporated’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.65% (day), 3.70% (last week), and 2.48% (last month), respectively.

Corcept Therapeutics Incorporated’s Stock Yearly Top and Bottom Value

Corcept Therapeutics Incorporated’s stock is valued at $20.34 at 06:22 EST, way below its 52-week high of $31.18 and way higher than its 52-week low of $16.52.

Corcept Therapeutics Incorporated’s Moving Average

Corcept Therapeutics Incorporated’s worth is below its 50-day moving average of $20.66 and below its 200-day moving average of $21.61.

5. Afya (AFYA)

20.6% sales growth and 9.71% return on equity

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil.

Afya’s sales growth this year is anticipated to be 30.7% and 24.9% for next year.

Year-on-year quarterly revenue growth grew by 35.8%, now sitting on 1.42B for the twelve trailing months.

Volume

Today’s last reported volume for Afya is 57431 which is 52.21% below its average volume of 120184.

Afya’s sales growth for the next quarter is 20.6%. The company’s growth estimates for the present quarter and the next is 20% and 33.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.71%.

Volatility

Afya’s last day, last week, and last month’s current volatility was 4.46%, 1.90%, and 3.05%, respectively.

Afya’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.53% (day), 4.50% (last week), and 4.57% (last month), respectively.

Afya’s Stock Yearly Top and Bottom Value

Afya’s stock is valued at $19.71 at 06:22 EST, way below its 52-week high of $29.01 and higher than its 52-week low of $18.44.

Afya’s Moving Average

Afya’s value is under its 50-day moving average of $20.74 and way below its 200-day moving average of $22.75.

6. Perficient (PRFT)

18% sales growth and 10.89% return on equity

Perficient, Inc. provides digital consultancy services and solutions in the United States.

Perficient’s sales growth this year is anticipated to be 20.1% and 12.3% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 673.71M for the twelve trailing months.

Volume

Today’s last reported volume for Perficient is 176085 which is 56.67% below its average volume of 406448.

Perficient’s sales growth for the next quarter is 18%. The company’s growth estimates for the current quarter and the next is 26.9% and 10.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.89%.

Volatility

Perficient’s last day, last week, and last month’s current volatility was 1.64%, 0.98%, and 1.61%, respectively.

Perficient’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.81% (day), 2.76% (last week), and 2.96% (last month), respectively.

Perficient’s Stock Yearly Top and Bottom Value

Perficient’s stock is valued at $120.88 at 06:22 EST, below its 52-week high of $124.71 and way above its 52-week low of $37.42.

Perficient’s Moving Average

Perficient’s worth is higher than its 50-day moving average of $117.74 and way above its 200-day moving average of $87.25.

7. West Bancorporation (WTBA)

15.3% sales growth and 18.3% return on equity

West Bancorporation, Inc. operates as the financial holding company for West Bank that provides community banking and trust services to individuals and small- to medium-sized businesses in the United States.

West Bancorporation’s sales growth this year is expected to be 19.2% and a negative 1.7% for next year.

Year-on-year quarterly revenue growth grew by 40.2%, now sitting on 93.38M for the twelve trailing months.

Volume

Today’s last reported volume for West Bancorporation is 11425 which is 58.09% below its average volume of 27265.

West Bancorporation’s sales growth for the next quarter is 15.3%. The company’s growth estimates for the current quarter and the next is 44.9% and 44.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.3%.

Volatility

West Bancorporation’s last day, last week, and last month’s current volatility was 0.19%, 0.64%, and 1.38%, respectively.

West Bancorporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.77% (day), 1.92% (last week), and 2.50% (last month), respectively.

West Bancorporation’s Stock Yearly Top and Bottom Value

West Bancorporation’s stock is valued at $30.71 at 06:22 EST, under its 52-week high of $31.98 and way higher than its 52-week low of $16.04.

West Bancorporation’s Moving Average

West Bancorporation’s worth is higher than its 50-day moving average of $29.97 and above its 200-day moving average of $28.06.

8. Federal Realty Investment Trust (FRT)

6.4% sales growth and 6.07% return on equity

Federal Realty is a recognized leader in the ownership, operation and redevelopment of high-quality retail-based properties located primarily in major coastal markets from Washington, D.C. to Boston as well as San Francisco and Los Angeles.

Federal Realty Investment Trust’s sales growth this year is anticipated to be 8.2% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 34.5%, now sitting on 873.25M for the twelve trailing months.

Volume

Today’s last reported volume for Federal Realty Investment Trust is 410907 which is 9.33% below its average volume of 453206.

Federal Realty Investment Trust’s sales growth for the next quarter is 6.4%. The company’s growth estimates for the ongoing quarter and the next is 200% and negative -64.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.07%.

Volatility

Federal Realty Investment Trust’s last day, last week, and last month’s current volatility was 0.56%, 0.37%, and 0.94%, respectively.

Federal Realty Investment Trust’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.75% (day), 1.60% (last week), and 1.87% (last month), respectively.

Federal Realty Investment Trust’s Stock Yearly Top and Bottom Value

Federal Realty Investment Trust’s stock is valued at $123.04 at 06:22 EST, under its 52-week high of $125.00 and way higher than its 52-week low of $67.01.

Federal Realty Investment Trust’s Moving Average

Federal Realty Investment Trust’s value is above its 50-day moving average of $120.50 and above its 200-day moving average of $116.11.

LEAVE A REPLY

Please enter your comment!
Please enter your name here